Royal Philips Electronics has released the BiPAP autoSV Advanced, its latest device for treating complicated sleep-disordered breathing patients.
The system is designed to effectively manage challenging sleep apnea cases.
__________
continuous positive airway pressure
Jan
22
2010
New advanced bi-level system provides effective treatment of complicated sleep apnea patients
__________
Nov
9
2009
Respironics’ CEO praises CDC on sleep deprivation outreach as an “important public health issue”
Don Spence, chief executive officer of Philips Home Healthcare Solutions, has issued a written statement endorsing the Centers for Disease Control and Prevention (CDC) educational initiative to increase awareness about sleep deprivation.
__________
Royal Philips Electronics today showcased the next generation Philips Respironics Sleep Therapy System at Medtrade 2009, a conference and expo for the home medical equipment industry.
The arrival of the new product line brings advances in sleep apnea therapy, the manufacturer says, that will benefit millions of sleep apnea sufferers, as well as bring new solutions to healthcare providers trying to meet today’s healthcare challenges.
__________
The eyes may be the window into the soul, but they may also contain important medical information. According to research findings presented at the American Thoracic Society’s 105th International Conference in San Diego, patients who have been diagnosed with both diabetes and retinopathy should also be screened for obstructive sleep apnea (OSA).
“We know from our earlier research that 23 percent of men with type 2 diabetes have OSA and this is under-recognized and under-treated,” said Sophie D. West, M.D., of the Oxford Centre for Respiratory Medicine in the United Kingdom, who led the research. “This study suggests that OSA is linked to retinopathy in type 2 diabetes.”
__________
A recently published study that is the first to assess the effectiveness of treating sleep disorders in adults with a traumatic brain injury (TBI) shows treatment may result in the objective resolution of the sleep disorder without improvements in daytime sleepiness or neuropsychological function.
Results show that in brain-injured subjects with obstructive sleep apnea, three months of treatment with CPAP therapy dramatically reduced the severity of OSA from 31.4 to 3.8 apneas and hypopneas per hour of sleep; however, there was no demonstrable improvement in measures of daytime sleepiness.
__________
People with even minimally symptomatic obstructive sleep apnea (OSA) may be at increased risk for cardiovascular disease because of impaired endothelial function and increased arterial stiffness, according to a study in the November 2008 issue of American Journal of Respiratory and Critical Care Medicine.
Their findings suggested that minimally symptomatic OSA is a cardiovascular risk factor to a degree not previously known.
__________
Carbon monoxide (CO) levels in a patient’s blood may determine the severity of a patient’s obstructive sleep apnea (OSA), according to a study published in the November 2008 issue of Chest.
Masayoshi Kobayashi, M.D., of the Yokohama City University Graduate School of Medicine in Yokohama, Japan, and colleagues determined CO levels in 35 patients with OSA and 17 healthy controls matched for age, both before and after polysomnography.
__________
A study published in the Journal of Clinical Sleep Medicine suggests screening patients with Type 2 diabetes for obstructive sleep apnea (OSA) and treating those who have obstructive sleep apnea with xPAP therapy could improve the management of their hyperglycemia and might favorably influence their long-term prognosis.
According to Arthur Dawson, M.D., Scripps Clinic Sleep Center, it is not surprising that many diabetics have sleep apnea since Type 2 diabetes and obstructive sleep apnea are both conditions that are becoming much more common because of the obesity epidemic.
__________
People with even minimally symptomatic obstructive sleep apnea (OSA) may be at increased risk for cardiovascular disease because of impaired endothelial function and increased arterial stiffness, according to a study from the Oxford Centre for Respiratory Medicine in the United Kingdom.
“It was previously known that people with OSA severe enough to affect their daytime alertness and manifest in other ways are at increased risk of cardiovascular disease, but this finding suggests that many more people — some of whom may be completely unaware that they even have OSA — are at risk than previously thought,” said lead author of the study, Malcolm Kohler, M.D.
__________
